A citation-based method for searching scientific literature

R E Ratner, S C L Gough, C Mathieu, S Del Prato, B Bode, H Mersebach, L Endahl, B Zinman. Diabetes Obes Metab 2013
Times Cited: 244



Yukiko Onishi, Yasuhiko Iwamoto, Soon Jib Yoo, Per Clauson, Søren C Tamer, Sungwoo Park. J Diabetes Investig 2013
Times Cited: 76




List of shared articles



Times cited

One-year safety and effectiveness of insulin degludec in patients with diabetes mellitus in routine clinical practice in India-TRUST (Tresiba real-world use study).
Jothydev Kesavadev, L Sreenivasa Murthy, Tirthankar Chaudhury, Sadasiva Rao Yalamanchi, J Giri, Sunil Gupta, Sanjeev Phatak, K D Modi, Sanjay Chatterjee, Aparna Manjunath,[...]. Metabol Open 2022
0


The Value of Insulin Degludec in Frail Older Adults with Type 2 Diabetes.
W David Strain, Angharad R Morgan, Marc Evans. Diabetes Ther 2021
1

Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes.
Stewart Harris, Martin J Abrahamson, Antonio Ceriello, Guillaume Charpentier, Marc Evans, Roger Lehmann, Andreas Liebl, Sultan Linjawi, Richard I G Holt, Nóra Hosszúfalusi,[...]. Drugs 2020
3



Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes.
Sudesna Chatterjee, Kamlesh Khunti, Melanie J Davies. Drugs 2019
13

Reporting of hypoglycaemia in clinical trials of basal insulins: A need for consensus.
Brian M Frier, Alexandria Ratzki-Leewing, Stewart B Harris. Diabetes Obes Metab 2019
2

Efficacy and safety of insulin degludec U100 and insulin glargine U100 in combination with meal-time bolus insulin in hospitalized patients with type 2 diabetes: an open-label, randomized controlled study.
Jun Suzuki, Tadashi Yamakawa, Mari Oba, Jo Nagakura, Erina Shigematsu, Haruka Tamura, Kenichiro Takahashi, Yoshihisa Okamoto, Rika Sakamoto, Minori Shinoda,[...]. Endocr J 2019
7